Showing 3,861 - 3,880 results of 16,434 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', query time: 0.72s Refine Results
  1. 3861

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  2. 3862

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  3. 3863

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  4. 3864

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  5. 3865

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  6. 3866

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  7. 3867

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…HDAC8 is a therapeutic target with great promise for breast cancer. Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  8. 3868

    Different scenarios of hidden hearing loss have additive effects on SGN activity. by Maral Budak (6680351)

    Published 2021
    “…Normalized CAP amplitudes (C) and CAP latencies (D) for different myelinopathy and synaptopathy cases for various sound levels, averaged over 50 simulations. Shaded areas correspond to the standard error of the mean.…”
  9. 3869

    Evaluation of Efficiency of Liposome-Entrapped Iridium(III) Complexes Inhibiting Tumor Growth In Vitro and In Vivo by Huiyan Hu (9376570)

    Published 2024
    “…In addition, we also found that 3alip, 3blip, and 3clip triggered ferroptosis and autophagy. …”
  10. 3870

    Notch signaling regulates the responses of lipopolysaccharide-stimulated macrophages in the presence of immune complexes by Wipawee Wongchana (5367968)

    Published 2018
    “…In the presence of immune complexes (ICs), activated macrophages have decreased IL-12 production and increased IL-10 production and presumably act as regulatory macrophages. …”
  11. 3871
  12. 3872

    Keeping constant channel number as length of unmyelinated segment, <i>L</i><sub><i>u</i></sub>, is increased leads to similar effects on cumulative CAP as keeping constant channel... by Maral Budak (6680351)

    Published 2021
    “…Normalized CAP amplitudes (C) and CAP latencies (D) for various sound levels, averaged over 50 simulations. Shaded areas correspond to the standard error of the mean.…”
  13. 3873

    Maintaining channel density at the heminode as its length, <i>L</i><sub><i>h</i></sub>, is varied reduces effects on cumulative CAP compared to keeping constant channel number. by Maral Budak (6680351)

    Published 2021
    “…Normalized CAP amplitudes (C) and CAP latencies (D) for various sound levels, averaged over 50 simulations. Shaded areas correspond to the standard error of the mean.…”
  14. 3874
  15. 3875

    Image_5_Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®).... by Salam Alkindi (11601856)

    Published 2021
    “…In this evaluable cohort of 44 patients, the mean SF (±SD) reduced marginally from 4,311 to 4,230 ng/ml, mean Liver T2<sup>*</sup> MRI dropped from 12 to 10.3 mg/gm dry weight, while the mean cardiac T2<sup>*</sup>MRI improved from 36.8 to 39.5 ms. …”
  16. 3876
  17. 3877
  18. 3878
  19. 3879
  20. 3880

    Modifying the thresholds of MT and HT fibers does not have a significant effect on CAP features for different HHL scenarios. by Maral Budak (6680351)

    Published 2021
    “…Normalized CAP amplitudes (D) and CAP latencies (D) for different myelinopathy and synaptopathy cases for various sound levels, averaged over 50 simulations. Shaded areas correspond to the standard error of the mean.…”